MÖLNDAL,, Sweden--(BUSINESS WIRE)--Regulatory News:
Arcam (STO:ARCM), listed on NASDAQ OMX, has received an EBM system order from one of the leading implant manufacturers in China.
”This new order from a large Chinese implant manufacturer confirms again the importance of the market in China. We are well positioned in the region with our own support organization in China and installations both with research institutes and industrial clients”, says Magnus René, CEO of Arcam.
The above information has been made public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published on January 22, 2014.
Arcam provides a cost-efficient Additive Manufacturing solution for production of metal components. The technology offers freedom in design combined with excellent material properties and high productivity. Arcam’s market is global with customers mainly in the orthopedic and aerospace industries. The company was founded in 1997 and is listed on NASDAQ OMX Stockholm, Sweden. Head office and production facilities are located in Mölndal, Sweden. Support offices are located in the US, UK, Italy and China.
________________________________________________________________________________________
Arcam AB • Krokslätts Fabriker 27A • SE-431 37 Mölndal, Sweden • 46-31-710 32 00 • www.arcam.com
This information was brought to you by Cision http://news.cision.com